Benzinga

Benzinga Japan

Benzinga

Benzinga Japan

Benzinga

Benzinga Japan
月曜日, 8 24

Hims & Hers Health Inc

HIMSNYSE
Trade with Public
Trade with Public
$33.78
1.926.03%
近くで: Aug 21, 5:00 PM EST
$33.73
-0.055-0.16%
時間外: Aug 21, 7:53 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Hims & Hers Health Financials

Hims & Hers Health (HIMS) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Hims & Hers Health: Investments Necessary For Long-Term Incremental Growth, Says Bullish Analyst

HIMS stock edges lower after mixed Q2 results. Needham analyst maintains Buy rating, raises PT to $42. Company's revenue up 38.2% YoY.
Priya Nigam

Hims & Hers Shares Drop After Mixed Q2 Earnings — Details

Hims & Hers posted Q2 results - here are the details you need to know.
Erica Kollmann

PRO
Hims & Hers Health Sees Q3 Sales $880.000M-$900.000M vs $793.071M Est

Hims & Hers Health (NYSE:HIMS) sees Q3 sales of $880.000 million-$900.000 million vs $793.071 million analyst estimate.
Benzinga Newsdesk

PRO
Hims & Hers Health Raises FY2026 Sales Guidance from $2.800B-$3.000B to $3.100B-$3.300B vs $2.928B Est

Hims & Hers Health (NYSE:HIMS) raises FY2026 sales outlook from $2.800 billion-$3.000 billion to $3.100 billion-$3.300 billion vs $2.928 billion estimate.
Benzinga Newsdesk

PRO
Hims & Hers Health Q2 EPS $(0.37) Misses $(0.03) Estimate, Sales $753.214M Beat $699.889M Estimate

Hims & Hers Health (NYSE:HIMS) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.03) by 1133.33 percent. This is a 317.65 percent decrease over earnings of $0.17 per
Benzinga Newsdesk

Hims & Hers Health Likely To Report Q2 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

HIMS to release Q2 earnings on Aug. 10, expected to report a loss of 5 cents/share. FDA panel voted to add BPC-157 to compounding list. Stock rose 6.5% on Friday.
Avi Kapoor

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

Benzinga

Benzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved